Bayer announced the submission of a marketing authorization application to the Ministry of Health, Labour, and Welfare (MHLW) in Japan, seeking approval of finerenone in adult patients with… read more.
A new blood test has an 80% accuracy in predicting preterm preeclampsia, according to a study published today, Feb. 12, in the journal Nature Medicine. The condition, which… read more.
A meta-analysis evaluating bleeding risks among atrial fibrillation (AF) patients treated with therapeutic-dose non-vitamin K oral anticoagulants (NOACs) and single antiplatelet therapy (aspirin) indicates that rates of major… read more.
Use of a salt substitute is not only safe but reduces recurrent stroke and saves lives, researchers reported on Feb. 5, 2025 in JAMA Cardiology. “The results suggest… read more.
A 240-year-old drug called digoxin could save the National Health Service (NHS) at least £100 million each year when treating older patients with atrial fibrillation and heart failure…. read more.
Bayer announced the submission of a marketing authorization application to the EMA, seeking approval in the EU for the use of finerenone in adult patients with HF with… read more.
Novo Nordisk announced that the FDA has approved Ozempic (semaglutide injection) to reduce the risk of kidney disease worsening, kidney failure (end-stage kidney disease), and death due to… read more.
A recent study1 from Purdue University scientists reveals following a consistent dietary pattern that features lean red meat can contribute to gut microbiota balance and support cardiovascular health…. read more.
Heart disease kills more people than any other cause as many of the risks factors that contribute to it remain on the rise, according the data reported in… read more.
About 6.7 million American adults are living with heart failure (HF), and prevalence is expected to reach more than 8 million by 2030.[1] While there is no cure… read more.
Nippon Shinyaku Co., Ltd. announced that it has obtained approval from the Ministry of Health, Labor and Welfare (MHLW) in Japan for Uptravi tablets 0.2 mg and 0.4… read more.
Advances in technology have made it increasingly easier for people to self-monitor their heart health whether it’s via a smart device on their wrist or finger or a… read more.
Advertisment
If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.
You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.
